Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 enero 2017

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival

James X. Chen, Steven Rose, Sarah B. White, Ghassan El-Haddad, Nicholas Fidelman, Hooman Yarmohammadi, Winifred Hwang, Daniel Y. Sze, Nishita Kothary, Kristen Stashek, E. Paul Wileyto, Riad Salem, David C. Metz, Michael C. Soulen

Purpose: The purpose of the study was to evaluate prognostic factors for survival outcomes following embolotherapy for neuroendocrine tumor (NET) liver metastases.

01 enero 2017

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. Predicting Outcomes After Chemo-Embolization in Patients with Advanced-Stage Hepatocellular Carcinoma: An Evaluation of Different Radiologic Response Criteria

Andrew J. Gunn, Rahul A. Sheth, Brandon Luber, Minh-Huy Huynh, Niranjan R. Rachamreddy, Sanjeeva P. Kalva

Purpose: The purpse of this study was to evaluate the ability of various radiologic response criteria to predict patient outcomes after trans-arterial chemo-embolization with drug-eluting beads (DEB-TACE) in patients with advanced-stage (BCLC C) hepatocellular carcinoma (HCC).

01 enero 2017

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. Embolization for Thoracic Duct Collateral Leakage in High-Output Chylothorax After Thoracic Surgery

Shuji Kariya, Miyuki Nakatani, Rie Yoshida, Yutaka Ueno, Atsushi Komemushi, Noboru Tanigawa

Purpose: This study was designed to investigate thoracic duct collateral leakage and the supply route of lymphatic fluid by lymphangiography and transcatheter thoracic ductography and to evaluate the results of embolization for thoracic duct collateral leakage performed to cut off this supply route.

01 enero 2017

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. Transcatheter Arterial Embolization with N-Butyl-2-Cyanoacrylate in the Management of Spontaneous Hematomas

Umut Ozyer

Introduction: Spontaneous hematoma refractory to conservative management is a potentially serious condition that requires prompt diagnosis and intervention. The purpose of this study was to evaluate the performance of computed tomography (CT) in the treatment planning and to report the effectiveness of transcatheter embolization with N-butyl-2-cyanoacrylate (NBCA).

01 enero 2017

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. The Essentials of Parathyroid Hormone Venous Sampling

Bedros Taslakian, Scott O. Trerotola, Barry Sacks, Rahmi Oklu, Amy Deipolyi

Hyperparathyroidism is an excess of parathyroid hormone in the blood due to over-activity of one or more parathyroid gland. Localization of abnormal glands with noninvasive imaging modalities, such as technetium sestamibi scan and cross-sectional imaging, has a high success rate. Parathyroid venous sampling is performed for patients with persistent or recurrent disease after previous parathyroid surgery, when repeat noninvasive imaging studies are negative or discordant. The success of invasive localization studies and results interpretation is dependent on the interventional radiologist’s understanding of the normal and ectopic anatomic locations of parathyroid glands, as well as their blood supply and venous drainage. Anatomic and technical considerations for selective parathyroid venous sampling are reviewed.

01 febrero 2017

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Outcomes of Esophageal Arterial Embolization for Treatment of Hemoptysis

Eui Yong Jeon, MD, Young Kwon Cho, MD, PhD, Heon Han, MD, PhD, Young Il Kim, MD, PhD, Lyo Min Kwon, MD, Yeol Lee, MD, PhD, Jung Gi Im, MD, PhD

Purpose: To investigate safety and efficacy of esophageal arterial embolization (EAE) in addition to bronchial arterial embolization (BAE) for treatment of hemoptysis as well as the importance and characteristics of esophageal arteries in patients with hemoptysis.

01 febrero 2017

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma

Bela Kis, MD, PhD, Jehan Shah, MD, Junsung Choi, MD, Ghassan El-Haddad, MD, Jennifer Sweeney, MD, Benjamin Biebel, MD, Eric Mellon, MD, Jessica M. Frakes, MD, Sarah E. Hoffe, MD, Mayer N. Fishman, MD, Ravi Shridhar, MD

Purpose: To evaluate safety and efficacy of transarterial hepatic radioembolization treatment of patients with liver-dominant metastatic renal cell carcinoma (RCC).

01 febrero 2017

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma

Kerstin Müller, PhD, Sanjit Datta, MS, Sonja Gehrisch, MS, Moiz Ahmad, PhD, Mohammed Ahmed Abdelrazek Mohammed, MD, Jarrett Rosenberg, PhD, Gloria L. Hwang, MD, John D. Louie, MD, Daniel Y. Sze, MD, PhD, Nishita Kothary, MD

Purpose: To identify computational and qualitative features derived from dual-phase cone-beam CT that predict short-term response in patients undergoing transarterial chemoembolization for hepatocellular carcinoma (HCC).

01 febrero 2017

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy

Stephen H. Gray, MD, Jared A. White, MD, Peng Li, PhD, Meredith L. Kilgore, PhD, David T. Redden, PhD, Ahmed K. Abdel Aal, MD, PhD, Heather N. Simpson, MD, Brendan McGuire, MD, Devin E. Eckhoff, MD, Derek A. Dubay, MD

Purpose: To measure transarterial chemoembolization utilization and survival benefit among patients with hepatocellular carcinoma (HCC) in the Surveillance, Epidemiology, and End Results (SEER) patient population.

01 febrero 2017

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Percutaneous Cryoablation for the Treatment of Recurrent Malignant Pleural Mesothelioma: Safety, Early-Term Efficacy, and Predictors of Local Recurrence

Fereidoun Abtin, MD, Matthew T. Quirk, MD, Robert D. Suh, MD, William Hsu, MD, Simon X. Han, MS, Grace-Hyun J. Kim, PhD, Scott Genshaft, MD, Jesse K. Sandberg, MD, Olga Olevsky, MD, Robert B. Cameron, MD

Purpose: To determine safety and early-term efficacy of CT–guided cryoablation for treatment of recurrent mesothelioma and assess risk factors for local recurrence.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.